Molbio Diagnostics Ltd vs Narayana Hrudayalaya Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Molbio Diagnostics Ltd is ₹ 1237 as of 23 Oct 15:30 . The P/E Ratio of Molbio Diagnostics Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Narayana Hrudayalaya Ltd changed from 44.6 on March 2022 to 40.7 on March 2026 . This represents a CAGR of -1.81% over 5 years The Market Cap of Molbio Diagnostics Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Narayana Hrudayalaya Ltd changed from ₹ 8299 crore on March 2021 to ₹ 32813 crore on March 2026 . This represents a CAGR of 25.75% over 6 years The revenue of Molbio Diagnostics Ltd for the Jun '26 is ₹ 411.48 crore as compare to the Mar '26 revenue of ₹ 565.41 crore. This represent the decline of -27.22% The revenue of Narayana Hrudayalaya Ltd for the Jun '26 is ₹ 2719 crore as compare to the Mar '26 revenue of ₹ 2623 crore. This represent the growth of 3.66% The ebitda of Molbio Diagnostics Ltd for the Jun '26 is ₹ 103.68 crore as compare to the Mar '26 ebitda of ₹ 163.51 crore. This represent the decline of -36.59% The ebitda of Narayana Hrudayalaya Ltd for the Jun '26 is ₹ 503.27 crore as compare to the Mar '26 ebitda of ₹ 533.16 crore. This represent the decline of -5.61% The net profit of Molbio Diagnostics Ltd changed from ₹ -23.94 crore to ₹ 52.74 crore over 5 quarters. This represents a CAGR of NaN% The net profit of Narayana Hrudayalaya Ltd changed from ₹ 201.49 crore to ₹ 207.27 crore over 9 quarters. This represents a CAGR of 1.26% The Dividend Payout of Molbio Diagnostics Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Narayana Hrudayalaya Ltd changed from 15.3 % on March 2022 to 18.28 % on March 2026 . This represents a CAGR of 3.62% over 5 years .

About Molbio Diagnostics Ltd

Molbio Diagnostics Limited was originally incorporated as Molbio Diagnostics Private Limited' at Panaji, as a private company dated October 20, 2000.
Thereafter, Company was converted from a private limited company to a public limited company, and the name of Company was changed to Molbio Diagnostics Limited, and a fresh certificate of incorporation dated January 16, 2025 was issued to Company by the RoC. Company is innovative point-of-care (POC) diagnostics company focused on expanding access to accurate, rapid and cost-effective healthcare technologies to diagnose infectious and non-communicable diseases.
The Company entered into a joint venture agreement in August, 2011 with Bigtec Innovations Private Limited and Bigtec Private Limited, which started operations in 2000.
Bigtec Innovations Private Limited got merged with the Company in 2015.

About Narayana Hrudayalaya Ltd

Narayana Hrudayalaya Limited was incorporated on 19 July 2000 by Dr. Devi Prasad Shetty as its Founder.
The Company is primarily engaged in the business of rendering medical and healthcare services.
It has a network of multispeciality, and super speciality hospitals spread across multiple locations.
The Company owns and operates certain hospitals and also enters into management agreements with hospitals under which the Company acquires the operating control of the hospitals. During the financial year ended 31 March 2016, Company acquired the entire remaining 26% in Narayana Hrudayalaya Surgical Hospital Private Limited (NHSHPL) from Infrastructure Development Corporation (Karnataka) Limited (IDECK) by paying Rs 3,025.60 Lacs as total purchase consideration to make NHSHPL as its wholly owned subsidiary.

FAQs for the comparison of null and Narayana Hrudayalaya Ltd

Which company has a larger market capitalization, Molbio Diagnostics Ltd or Narayana Hrudayalaya Ltd?

Market cap of Molbio Diagnostics Ltd is 14,262 Cr while Market cap of Narayana Hrudayalaya Ltd is 33,658 Cr

What are the key factors driving the stock performance of Molbio Diagnostics Ltd and Narayana Hrudayalaya Ltd?

The stock performance of Molbio Diagnostics Ltd and Narayana Hrudayalaya Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Molbio Diagnostics Ltd and Narayana Hrudayalaya Ltd?

As of October 25, 2026, the Molbio Diagnostics Ltd stock price is INR ₹1237.65. On the other hand, Narayana Hrudayalaya Ltd stock price is INR ₹1647.0.

How do dividend payouts of Molbio Diagnostics Ltd and Narayana Hrudayalaya Ltd compare?

To compare the dividend payouts of Molbio Diagnostics Ltd and Narayana Hrudayalaya Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.